Showing results (51-60 of 212) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of VaterMichael J Overman, Gauri R Varadhachary, Scott Kopetz, et al.
Cancer Treatment Reviews|July 1, 2025
Systematic literature review of intravenous versus subcutaneous administration of oncology therapies: A clinical, economic and patient perspectiveSaby George, Maria T Bourlon, Michael J Overman, et al.
Cancer|September 2, 2008
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinomaMichael J Overman, Scott Kopetz, Sijin Wen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2012
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancerRenata Ferrarotto, Karime Machado, Milena P Mak, et al.
The Oncologist|June 1, 2019
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal CancerMichael A Morse, Michael J Overman, Leighanne Hartman, et al.
JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Clinical Colorectal Cancer|September 17, 2008
Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 casesMichael J Overman, David Fogelman, Aref Al-Kali, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
BMC Cancer|May 17, 2017
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgeryMarc Uemura, Wei Qiao, Keith Fournier, et al.
Plos One|October 22, 2013
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancerChristopher H Lieu, Hai Tran, Zhi-Qin Jiang, et al.
Pageof 22